688189 Stock Overview
Hunan Nucien Pharmaceutical Co., Ltd., a pharmaceutical company, engages in the research and development, production, and sale of chemical drugs in China.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Hunan Nucien Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥7.08 |
| 52 Week High | CN¥11.52 |
| 52 Week Low | CN¥5.41 |
| Beta | 0.16 |
| 1 Month Change | -11.17% |
| 3 Month Change | -0.98% |
| 1 Year Change | -32.20% |
| 3 Year Change | -64.96% |
| 5 Year Change | n/a |
| Change since IPO | -78.68% |
Recent News & Updates
Recent updates
Shareholder Returns
| 688189 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 5.5% | 5.7% | 4.2% |
| 1Y | -32.2% | -11.0% | -13.2% |
Return vs Industry: 688189 underperformed the CN Pharmaceuticals industry which returned -11% over the past year.
Return vs Market: 688189 underperformed the CN Market which returned -13.2% over the past year.
Price Volatility
| 688189 volatility | |
|---|---|
| 688189 Average Weekly Movement | 9.7% |
| Pharmaceuticals Industry Average Movement | 7.7% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.6% |
| 10% least volatile stocks in CN Market | 5.2% |
Stable Share Price: 688189 has not had significant price volatility in the past 3 months.
Volatility Over Time: 688189's weekly volatility (10%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 360 | n/a | www.nucien.com |
Hunan Nucien Pharmaceutical Co., Ltd., a pharmaceutical company, engages in the research and development, production, and sale of chemical drugs in China. It focuses on anti-influenza, cardiovascular, antibiotics, antipyretics, anti-allergy, pain relief, diabetes, cerebrovascular, respiratory, anti-tumor, and other pharmaceutical fields. Hunan Nucien Pharmaceutical Co., Ltd.
Hunan Nucien Pharmaceutical Co., Ltd. Fundamentals Summary
| 688189 fundamental statistics | |
|---|---|
| Market cap | CN¥1.94b |
| Earnings (TTM) | -CN¥5.01m |
| Revenue (TTM) | CN¥553.21m |
3.5x
P/S Ratio-387.4x
P/E RatioIs 688189 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 688189 income statement (TTM) | |
|---|---|
| Revenue | CN¥553.21m |
| Cost of Revenue | CN¥155.19m |
| Gross Profit | CN¥398.02m |
| Other Expenses | CN¥403.03m |
| Earnings | -CN¥5.01m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.018 |
| Gross Margin | 71.95% |
| Net Profit Margin | -0.91% |
| Debt/Equity Ratio | 22.0% |
How did 688189 perform over the long term?
See historical performance and comparison